Icon PLC (ICLR): Shareholders' Equity

Annual figures by period end, from SEC filings.

$9.19B
As of 2025-12-31
+2.7%
3-year compound annual growth
+37.8%
5-year compound annual growth
+28.3%
10-year compound annual growth
$9.44B2008-12-31: $456.37M2009-12-31: $572.25M2010-12-31: $670.00M2011-12-31: $681.54M2012-12-31: $754.58M2013-12-31: $910.58M2014-12-31: $950.21M2015-12-31: $763.10M2016-12-31: $945.17M2017-12-31: $1.19B2018-12-31: $1.35B2019-12-31: $1.62B2020-12-31: $1.85B2021-12-31: $8.07B2022-12-31: $8.50B2023-12-31: $9.21B2024-12-31: $9.44B2025-12-31: $9.19B$9.19B
2008-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$9.19B-2.6%2026-05-27, Balance as of period end
2024-12-31$9.44B+2.5%2026-05-27, Balance as of period end
2023-12-31$9.21B+8.4%2026-05-27, Balance as of period end
2022-12-31$8.50B+5.3%2025-02-21, Balance as of period end
2021-12-31$8.07B+336.0%2024-02-23, Balance as of period end
2020-12-31$1.85B+14.3%2023-02-24, Balance as of period end
2019-12-31$1.62B+19.5%2022-03-01, Balance as of period end
2018-12-31$1.35B+13.7%2021-02-24, Balance as of period end
2017-12-31$1.19B+26.0%2020-02-27, Balance as of period end
2016-12-31$945.17M+23.9%2019-03-01, Balance as of period end
2015-12-31$763.10M-19.7%2018-02-28, Balance as of period end
2014-12-31$950.21M+4.4%2017-02-28, Balance as of period end
2013-12-31$910.58M+20.7%2016-03-23, Balance as of period end
2012-12-31$754.58M+10.7%2015-03-12, Balance as of period end
2011-12-31$681.54M+1.7%2014-03-12, Balance as of period end
2010-12-31$670.00M+17.1%2013-03-06, Balance as of period end
2009-12-31$572.25M+25.4%2012-03-02, Balance as of period end
2008-12-31$456.37Mn/a2011-03-22, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Icon PLC (ICLR)2025-12-31$9.19B-2.6%
Incyte Corp (INCY)2025-12-31$5.17B+49.9%
Iqvia Holdings Inc. (IQV)2025-12-31$6.63B+9.3%
Charles River Laboratories International, Inc. (CRL)2025-12-27$3.17B-8.6%
Medpace Holdings, Inc. (MEDP)2025-12-31$459.07M-44.4%
NRC Health (NRC)2025-12-31$13.99M-55.3%
MaxCyte, Inc. (MXCT)2025-12-31$171.49M-16.9%
OmniAb, Inc. (OABI)2025-12-31$267.03M-7.2%
Foxo Technologies Inc. (FOXO)2025-12-31$11.14M+109.3%

Compare ICLR, INCY, IQV, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗